PHONE: (877) 667-4689
FAX: (877) 626-2702

Allergy Newsroom

October 3, 2016  All-American Allergy Alternatives, LLC announces the availability of allergy toothpaste, also known as Oral Mucosal Immunotherapy (OMIT). Allergy toothpaste enables the regular administration of allergy immunotherapy while a user brushes their teeth. Allergy toothpaste is custom-formulated for each patient by prescription and is available in mint and berry flavors.

September 2 , 2016  AAAAI’s School-based Asthma Management Program (SAMPRO™) aims to improve the care of asthmatic children in schools. SAMPRO™ Toolkit contains standardized recommendations and resources to allow implementation.    

July 26, 2016  Allergy sufferers find relief in immunotherapy toothpaste.  Fox News Health.

April 25, 2016 
Nasdaq Globe Newswire Press Release: “Allovate Therapeutics Announces Positive Results of Proof-of-Concept Study of Oral Mucosal Immunotherapy (OMIT)”   

March 23, 2016  Spring Allergy Capitals™ Report Ranks The Most Challenging Cities Nationwide For Allergies   

March 4, 2016  Eating peanut in early years reduces the risk of peanut allergy, even with later avoidance. New England Journal of Medicine Peanut Study Makes Debut at AAAAI Annual Meeting.  

June 11, 2015  Dosing of sublingual immunotherapy for allergic rhinitis: evidence-based review with recommendations . Bryan D. Leatherman MD, Ayesha Khalid MD, Stella Lee MD, Kevin McMains MD, Jacques Peltier MD, Michael P. Platt MD, Robert J. Stachler MD, Elina Toskala MD, PhD, Guy Tropper MD, Giri Venkatraman MD, Sandra Y. Lin MD

February 3, 2015  American Academy of Otolaryngic Allergy (AAOAF) Clinical Care Statements: Evidence-based summaries on recommended therapies and practices from the current medical literature.

Updated: October 3, 2016

Patient Disclaimer